Korea Arlico Pharm financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

알리코제약KRX:260660 · KOSDAQ · Healthcare

₩2,260-1.31%

2026-10-02 close

Korea Arlico Pharm's published financial data is dated 2026-10-04. 2024 revenue was KRW 190.44B. 2024 operating profit was −KRW 5.09B.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy